Here’s what you should know.
1. Dr. Schiff was recognized for his level of training and experience with NeoTract’s UroLift System. He uses the system to treat symptoms associated with benign prostatic hyperplasia.
2. Dr. Schiff said of the designation, “I am proud to be a national leader in treating patients with this durable and effective treatment.”
3. The UroLift system provides BPH patients relief. According to randomized study data, patients treated with the UroLift system experienced symptom relief with minimal side effects, the press release notes.
More articles on leadership:
6 trends in medical group CEO compensation — up 7.1% in 2017
American Society of Anesthesiologists survey shows widespread drug shortages harm patient care
ABC urges practices to keep HIPAA compliance on their radar — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.